ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 1000

$707K Total Retail Price of All Prescriptions

Rank: 140 out of 1000

588 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 11,263 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,557 925 S3 1 1
SIMVASTATIN 592 376 2 3
OMEPRAZOLE 408 291 3 2
LEVOTHYROXINE SODIUM 371 273 4 4
TRAMADOL HCL 364 223 5 13
LISINOPRIL 318 219 6 5
FUROSEMIDE 311 201 7 7
ZOLPIDEM TARTRATE 299 205 8 16
NEXIUM 276 177 9 23
MELOXICAM 271 201 10 14
HYDROCODONE BIT-IBUPROFEN 269 107 S3 10 11 253
ATENOLOL 269 178 11 24
PROMETHAZINE HCL 262 79 R 13 54
AMLODIPINE BESYLATE 259 214 14 6
CARVEDILOL 251 182 15 15
ATORVASTATIN CALCIUM 246 200 16 18
POTASSIUM CHLORIDE 237 156 17 10
METFORMIN HCL 235 121 18 8
GLIMEPIRIDE 234 158 19 34
RAMIPRIL 232 171 20 77
TIZANIDINE HCL 232 95 20 76
HYDROCHLOROTHIAZIDE 231 166 22 9
METFORMIN HCL ER 217 164 23 44
PANTOPRAZOLE SODIUM 211 157 24 28
METOPROLOL TARTRATE 185 128 25 19
FLUOXETINE HCL 158 105 26 51
LYRICA 153 73 27 47
AZITHROMYCIN 143 96 28 36
TRIAMTERENE-HCTZ 142 107 29 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 116 30 20
LOSARTAN POTASSIUM 139 113 31 25
DOXEPIN HCL 137 111 32 176
CITALOPRAM HBR 133 101 33 17
LOSARTAN-HYDROCHLOROTHIAZIDE 131 81 34 38
MECLIZINE HCL 128 117 35 80
TAMSULOSIN HCL 128 95 35 33
TRIAMTERENE-HYDROCHLOROTHIAZID 123 93 37 194
TRAZODONE HCL 120 54 38 29
CLONIDINE HCL 118 80 39 27
CLOPIDOGREL 113 57 40 35
METHOCARBAMOL 113 54 R 40 79
PROAIR HFA 110 72 42 50
ACETAMINOPHEN-CODEINE 110 24 S3 42 127
METOPROLOL SUCCINATE 108 105 44 21
CARISOPRODOL 106 61 R 45 72
KLOR-CON M20 104 95 46 66
CYCLOBENZAPRINE HCL 95 45 R 47 39
PAROXETINE HCL 92 45 48 63
CRESTOR 92 92 48 30
SPIRIVA 92 47 48 64
PROPRANOLOL HCL 91 60 51 135
GABAPENTIN 91 53 51 11
SERTRALINE HCL 91 32 51 26
ALLOPURINOL 91 50 51 31
WARFARIN SODIUM 80 73 55 22
ATENOLOL-CHLORTHALIDONE 78 59 56 206
AMITRIPTYLINE HCL 78 44 R 56 45
ESCITALOPRAM OXALATE 76 53 58 60
VENTOLIN HFA 76 54 58 83
TRILIPIX 71 36 60 218
PLAVIX 64 43 61 49
LOVASTATIN 62 62 62 41
IBUPROFEN 61 35 63 94
RANITIDINE HCL 61 27 63 37
COMBIVENT 59 23 65 193
LEVOFLOXACIN 59 36 65 73
AMOX TR-POTASSIUM CLAVULANATE 58 41 67 125
NAPROXEN 57 46 68 81
LEVETIRACETAM 56 25 69 128
BYSTOLIC 55 50 70 126
JANUVIA 54 42 71 85
VERAPAMIL ER 53 35 72 86
ESTRADIOL 53 26 R 72 114
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 28 72 101
PREDNISONE 52 28 75 42
DONEPEZIL HCL 51 51 76 32
METOCLOPRAMIDE HCL 51 36 76 99
TRICOR 50 17 78 141
PRADAXA 50 44 78 299
ADVAIR DISKUS 50 25 78 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.